# Fall Line Capital

> Fall Line Capital is a VC fund backing Biotechnology and Agriculture. See 59 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: San Mateo, United States
- Total investments: 59
- Last investment: Jan 2026
- Lead investor: 25%
- Last fund: May 2016
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/company/fall-line-capital/
- X (Twitter): https://twitter.com/falllinecapital
- Website: http://fall-line-capital.com/

Fall Line Capital is a VC fund in San Mateo focused on Biotechnology and Agriculture. Fall Line Capital primarily seeks investment in broadacre farmland and agricultural technologies. The firm engages in purchasing and actively managing farmland throughout the United States, and by investing in technology companies that are strategic to our landholdings. Fall Line Capital's primary goal is to realize untapped productivity infarmland.

## Contacts

5 contacts available for Fall Line Capital. Shizune tracks 14 team members at Fall Line Capital. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/fall-line-capital?utm_source=investor_profile

## Round sizes

| Stage | Round size |
| --- | --- |
| Seed | $3M–$14M |
| Series A | $7.5M–$32M |
| Series B | $19M–$46M |

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Biotechnology | 13 | 22% |
| Agriculture | 12 | 20% |
| AgTech | 10 | 17% |
| Farming | 8 | 14% |
| Software | 7 | 12% |

44 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series A | 14 | 24% |
| Seed | 13 | 22% |
| Series B | 11 | 19% |
| Series C | 6 | 10% |
| Series D | 3 | 5% |

9 stages tracked in total.

### Country

| Country | Investments | Share |
| --- | --- | --- |
| United States | 26 | 44% |
| Israel | 2 | 3% |
| Canada | 1 | 2% |
| France | 1 | 2% |
| Argentina | 1 | 2% |

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Libby Spalding | Vice President | 1 | https://shizune.co/investors/profile/libby-spalding-25a4 |
| Wade Condrey | Head of Southern Operations | 0 | https://shizune.co/investors/profile/wade-condrey |
| Yanniv Dorone | Senior Vice President | 1 | https://shizune.co/investors/profile/yanniv-dorone-74b4 |
| Baptiste Tellier | Director | 3 | https://shizune.co/investors/profile/baptiste-tellier |
| Clay Mitchell | Co-founder & Managing Director | 8 | https://shizune.co/investors/profile/clay-mitchell |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Ethernovia | Developing an Ethernet system sophisticated enough to process the bandwidth demands of the future requires expert integration at multiple levels. By unifying the vehicle network, the Ethernovia system has the power to dramatically alter how cars are designed and built. | $90M | Series B | Jan 20, 2026 |  |
| Ukko | Ukko is a biotech firm focused on creating safe immunotherapies for quickly addressing allergies and other immune-related disorders. The company utilizes a unique technology platform that combines computational protein design with mRNA/LNP delivery to alter allergenic proteins. This approach seeks to mitigate or eliminate the risks of severeallergic reactions while eliciting a protective immune response. The Company is focused on changing the approach to prevent allergic reactions at the molecular level, striving to offer a safer and more targeted alternative to conventional desensitization techniques. This will lessen the treatment burden while meeting the critical needs of those vulnerable to severe allergic reactions to peanuts, with possibilities for extending the solution to other major allergens like milk, tree nuts, and respiratory triggers. | $45M | Series C | Jan 08, 2026 |  |
| Ripple Foods | Ripple Foods specializes in making non-dairy milk with just as much protein as milk and half the sugar. Ripple has 8x the protein of almond milk and half the sugar of dairy milk. It’s high in bioavailable calcium (50% more than milk), potassium and provides a good source of omega-3s. It’s lower in calories than milk and best of all, it has thecreamy, delicious texture our dairy-free friends are missing. No more thin, chalky almond/ soy/ cashew milk.It was founded in 2014 and headquartered in Emeryville, California. | $17M |  | Dec 02, 2025 |  |
| Ansa Biotechnologies | Ansa Biotechnologies is manufactured via a chemical method that has remained essentially unchanged for 35 years and has approached a plateau. Ansa Biotechnologies is developing a novel DNA synthesis technology based on enzymes that will be more fast, accurate, and clean than existing methods. The technique promises to dramatically accelerateinnovation in biological research and engineering. | $46.4M | Series B | Oct 01, 2025 |  |
| Bonsai Robotics | Bonsai Robotics provides vision-based automation solutions for off-road vehicles, such as agricultural machines. The company also offers analytics and telematics to help growers improve their performance, efficiency, and safety. The company is based in San Jose, California. | $15M | Series A | Jan 28, 2025 |  |
| Vaulted Deep | Vaulted Deep provides proven technology solutions for permanent carbon removal to promote local environmental and community health. It is a spin-off of Advantek Waste Management Services. | $32.3M | Series A | Oct 02, 2024 |  |
| Arzeda | Arzeda develops innovative products powered by its Intelligent Protein Design Technology, using generative AI-driven design to create, validate, and manufacture new proteins and enzymes that enhance our lives and protect our planet. Arzeda commercializes with Fortune 500 go-to-market partners across multiple industries, enabling higher-performing,more cost-effective solutions that are healthier and sustainable. | $38M | Series C | Sep 17, 2024 |  |
| Arzeda | Arzeda develops innovative products powered by its Intelligent Protein Design Technology, using generative AI-driven design to create, validate, and manufacture new proteins and enzymes that enhance our lives and protect our planet. Arzeda commercializes with Fortune 500 go-to-market partners across multiple industries, enabling higher-performing,more cost-effective solutions that are healthier and sustainable. | $38M | Series B | Sep 17, 2024 |  |
| Micropep Technologies | Micropep Technologies developes a non-GMO new generation of bioherbicides and biostimulants. Micropep, founded in 2016 in Toulouse, focuses on bioherbicides and biostimulants. The company uses plants’ natural molecules, called “micro-peptides”, to temporarily control expression of their genes and regulate plant growth but leaving their DNA intact.The company currently works on four development programs: germination, flowering, growth, and weed control. | $29.3M | Series B | Jul 25, 2024 |  |
| Micropep Technologies | Micropep Technologies developes a non-GMO new generation of bioherbicides and biostimulants. Micropep, founded in 2016 in Toulouse, focuses on bioherbicides and biostimulants. The company uses plants’ natural molecules, called “micro-peptides”, to temporarily control expression of their genes and regulate plant growth but leaving their DNA intact.The company currently works on four development programs: germination, flowering, growth, and weed control. | $29.3M | Series B | Jul 25, 2024 |  |

10 of 59 investments shown.

## Co-investors
- [S2G Investments](https://shizune.co/investors/profile/s2g-ventures) — VC Fund, 15 deals together
- [Cavallo Ventures](https://shizune.co/investors/profile/cavallo-ventures) — VC Fund, 10 deals together
- [Leaps by Bayer](https://shizune.co/investors/profile/leaps-by-bayer) — VC Fund, 8 deals together
- [Google Ventures](https://shizune.co/investors/profile/google-ventures) — VC Fund, 7 deals together
- [Prelude Ventures](https://shizune.co/investors/profile/prelude-ventures-llc) — VC Fund, 7 deals together
- [FMC Ventures](https://shizune.co/investors/profile/fmc-ventures) — VC Fund, 5 deals together

## Similar investors

### Similar industry
- [SVG Ventures](https://shizune.co/investors/profile/svg-ventures) — VC Fund
- [SOSV](https://shizune.co/investors/profile/sosv) — VC Fund
- [Omnivore](https://shizune.co/investors/profile/omnivore-partners) — VC Fund

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

### Similar country
- [BDC Venture Capital](https://shizune.co/investors/profile/bdc-venture-capital) — VC Fund
- [Real Ventures](https://shizune.co/investors/profile/real-ventures) — VC Fund
- [Anges Quebec](https://shizune.co/investors/profile/anges-quebec) — VC Fund

## Featured in investor lists
- [Agriculture (agtech) Investors](https://shizune.co/investors/agriculture-agtech-investors)
- [Agriculture (agtech) VC Funds](https://shizune.co/investors/agriculture-agtech-vc-funds)
- [Agriculture (agtech) Investors](https://shizune.co/investors/agriculture-agtech-investors)
- [Agriculture (agtech) VC Funds](https://shizune.co/investors/agriculture-agtech-vc-funds)
- [Agriculture (agtech) Investors in United States](https://shizune.co/investors/agriculture-agtech-investors-united-states)
- [Agriculture (agtech) VC Funds in United States](https://shizune.co/investors/agriculture-agtech-vc-funds-united-states)

## FAQ

### What does Fall Line Capital invest in?

Fall Line Capital invests primarily in Biotechnology, Agriculture and AgTech startups, most often at Series A and Seed stage. Most of the 59 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### What is Fall Line Capital's check size?

Fall Line Capital typically joins rounds of $3M–$14M at Seed, $7.5M–$32M at Series A and $19M–$46M at Series B. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Fall Line Capital participates in.

### How do I contact Fall Line Capital?

Public channels for Fall Line Capital include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at Fall Line Capital?

The team at Fall Line Capital includes Libby Spalding (Vice President), Wade Condrey (Head of Southern Operations) and Yanniv Dorone (Senior Vice President), among 14 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co